Compugen Ltd

CGENNASDAQ • USD
2.02 USD
↘ 0.02 (0.98%)AT CLOSE (03:59 PM EST)
2.02
↘ 0.00 (0.15%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
2.02
↘ 0.00 (0.15%)
🔴Market: CLOSED

Shares of Compugen Ltd (CGEN) are trading at $2.03. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Nov 17, 2026.

Open?$1.99
High?$2.05
Low?$1.98
Prev. Close?$2.04
Volume?197.7K
Avg. Volume?N/A
VWAP?$2.02
Bid / Ask
Bid?$1.95 × 1.0K
Ask?$2.05 × 2.0K
Spread?$0.10
Midpoint?$2.00
Valuation & Ratios
Market Cap?193.2M
Shares Out?N/A
Float?93.5M
Float %?99.9%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Employees
75
Market Cap
193.2M
Industry
N/A
Listed
2000-08-11
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?2.70%Low
Short Interest?2.5M
Days to Cover?9.7
Free Float93.5M
Avg Daily Volume260.7K
Settlement Date2026-10-30